2007

Protein kinases technologies and opportunities for drug discovery authors, Sreten Bogdanovic, Beata Langlands

Visit USCO

Text Registration

Protein kinases technologies and opportunities for drug discovery authors, Sreten Bogdanovic, Beata Langlands

Status

Published

on 15 Jun 2007

Year of Creation

2003

Drug and Market Development Publications (employer for hire)

Registration Number

TX0005836787

on 15 Jun 2007

The U.S. Copyright record (Registration Number: TX0005836787) dated 15 Jun 2007, pertains to an electronic file (eService) titled "Protein kinases technologies and opportunities for drug discovery authors, Sreten Bogdanovic, Beata Langlands" created in 2003. The copyright holder is Drug and Market Development Publications (employer for hire), known for their creative contributions in text registration. For any inquiries concerning this copyrighted material, kindly reach out to Drug and Market Development Publications (employer for hire).

Drug and Market Development Publications (employer for hire)

Application Details

Registration Number

TX0005836787

Registration Date

6/15/2007

Year of Creation

2003

Agency Marc Code

DLC-CO

Record Status

New

Corporate Author

Drug and Market Development Publications

Physical Description

1 v

Personal Authors

Sreten Bogdanovic

Beata Langlands

Corporate Authors

Drug and Market Development Publications

Notes

Local Copyright Note: C.O. correspondence

Notes

Local Copyright Note: C.O. correspondence

Get your copyright registered todayThousands have copyrighted their assets.
What are you waiting for?

Show terms & conditions

Disclaimer: The information contained in this website is provided for informational purposes only, and should not be construed as legal advice. Although LegalForce RAPC Worldwide P.C., dba Trademarkia P.C., is a law firm (the “Firm”), your use of this website does not establish an attorney-client relationship with the Firm. Such a relationship can only be established after the Firm decides that it is willing and able to accept the engagement after a conflict check and after a written retainer agreement is agreed upon between you and the Firm. Your use of this website is also subject to our Terms of Use and Privacy Policy. ** The entry level subscription is a bundled price which requires a minimum of two billing cycles, or 6 months.